Agios Pharmaceuticals, Inc. (AGIO) ended last trading session with a change of -2.74 percent. It trades at an average volume of 807.35K shares versus 1.05M shares recorded at the end of last trading session. The share price of $47.48 is at a distance of 41.73 percent from its 52-week low and down -60.75 percent versus its peak. The company has a market cap of $1.85B and currently has 38.99M shares outstanding. The share price is currently -11.32 percent versus its SMA20, -6.15 percent versus its SMA50, and -16.17 percent versus its SMA200. The stock has a weekly performance of -5.7 percent and is -26.86 percent year-to-date as of the recent close.
On May 17, 2016 Agios Pharmaceuticals, Inc. (AGIO) updated financial guidance for the full year 2016 following today’s joint announcement that Agios and Celgene have established a new collaboration in metabolic immuno-oncology. As part of this new agreement, Agios will